StemoniX® microHeart® takes home the
CONNECT’s 30th Annual Most Innovative New Product Awards
San Diego December 1, 2017 – CONNECT, a premier innovation company accelerator in San Diego that creates and scales great companies in the technology and life sciences sectors, announced the winners of its 30th annual Most Innovative New Product Awards. The prestigious competition, which begins each year in the spring and culminates in the awards ceremony at the end of the year, is an annual signature event at CONNECT that recognizes and lauds stars of innovation and their latest groundbreaking products.
StemoniX’s microHeart in the Life Sciences Diagnostics category. The technology is used for screening drugs for heart toxicity.
“At Connect, we believe San Diego entrepreneurs are disrupting the world,” said Chief Executive Greg McKee. “Tonight’s winners demonstrate the incredible intellect and drive that continue to elevate our region’s innovation ecosystem.”
StemoniX® is transforming how medicine is discovered. By using skin or blood to create functioning microHearts® and microBrains®, StemoniX is making it possible to test medication on humans without that medication ever entering their bodies. This method of drug testing will speed up the search for new cures and enable the ability to test drug effectiveness on an individual person, so medicine works correctly the first time. For more information visit www.stemonix.com.